nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomefloxacin—TOP2A—Epirubicin—stomach cancer	0.262	0.358	CbGbCtD
Lomefloxacin—TOP2A—Doxorubicin—stomach cancer	0.139	0.19	CbGbCtD
Lomefloxacin—ABCC2—Irinotecan—stomach cancer	0.105	0.143	CbGbCtD
Lomefloxacin—ABCC2—Docetaxel—stomach cancer	0.0767	0.105	CbGbCtD
Lomefloxacin—ABCC2—Doxorubicin—stomach cancer	0.0572	0.078	CbGbCtD
Lomefloxacin—ABCC2—Methotrexate—stomach cancer	0.0554	0.0756	CbGbCtD
Lomefloxacin—CYP1A2—Fluorouracil—stomach cancer	0.0374	0.0511	CbGbCtD
Lomefloxacin—ABCC2—bile—stomach cancer	0.00295	0.479	CbGeAlD
Lomefloxacin—TOP2A—Topotecan—Irinotecan—stomach cancer	0.00183	0.279	CbGdCrCtD
Lomefloxacin—TOP2A—Paclitaxel—Docetaxel—stomach cancer	0.00129	0.196	CbGdCrCtD
Lomefloxacin—TOP2A—Cladribine—Floxuridine—stomach cancer	0.000957	0.146	CbGdCrCtD
Lomefloxacin—ABCC2—Constitutive Androstane Receptor Pathway—PPP2R4—stomach cancer	0.000488	0.0415	CbGpPWpGaD
Lomefloxacin—TOP2A—bone marrow—stomach cancer	0.000434	0.0706	CbGeAlD
Lomefloxacin—TOP2A—Idarubicin—Epirubicin—stomach cancer	0.000431	0.0656	CbGdCrCtD
Lomefloxacin—TOP2A—Doxorubicin—Epirubicin—stomach cancer	0.000431	0.0656	CbGdCrCtD
Lomefloxacin—TOP2A—Daunorubicin—Epirubicin—stomach cancer	0.000431	0.0656	CbGdCrCtD
Lomefloxacin—TOP2A—Idarubicin—Doxorubicin—stomach cancer	0.000399	0.0607	CbGdCrCtD
Lomefloxacin—TOP2A—Daunorubicin—Doxorubicin—stomach cancer	0.000399	0.0607	CbGdCrCtD
Lomefloxacin—TOP2A—Epirubicin—Doxorubicin—stomach cancer	0.000399	0.0607	CbGdCrCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PLAGL1—stomach cancer	0.00037	0.0315	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RBP1—stomach cancer	0.000351	0.0299	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—ID4—stomach cancer	0.000328	0.0279	CbGpPWpGaD
Lomefloxacin—CYP1A2—hematopoietic system—stomach cancer	0.000325	0.0529	CbGeAlD
Lomefloxacin—ABCC2—digestive system—stomach cancer	0.000322	0.0524	CbGeAlD
Lomefloxacin—Gatifloxacin—ALB—stomach cancer	0.000292	0.512	CrCbGaD
Lomefloxacin—Norfloxacin—CYP2A6—stomach cancer	0.000279	0.488	CrCbGaD
Lomefloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—stomach cancer	0.000274	0.0233	CbGpPWpGaD
Lomefloxacin—TOP2A—lymph node—stomach cancer	0.000269	0.0438	CbGeAlD
Lomefloxacin—ABCC2—endocrine gland—stomach cancer	0.000266	0.0433	CbGeAlD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—IGFBP3—stomach cancer	0.000262	0.0223	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYT1—stomach cancer	0.000259	0.022	CbGpPWpGaD
Lomefloxacin—SLC22A5—digestive system—stomach cancer	0.000249	0.0406	CbGeAlD
Lomefloxacin—ABCC2—Constitutive Androstane Receptor Pathway—CYP2A6—stomach cancer	0.000241	0.0205	CbGpPWpGaD
Lomefloxacin—ABCC2—liver—stomach cancer	0.00024	0.039	CbGeAlD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2D—stomach cancer	0.000237	0.0201	CbGpPWpGaD
Lomefloxacin—CYP1A2—digestive system—stomach cancer	0.000226	0.0368	CbGeAlD
Lomefloxacin—ABCC2—Irinotecan Pathway—APC—stomach cancer	0.000223	0.019	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aflatoxin B1 metabolism—GSTM1—stomach cancer	0.000197	0.0167	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TFF1—stomach cancer	0.000187	0.0159	CbGpPWpGaD
Lomefloxacin—CYP1A2—endocrine gland—stomach cancer	0.000187	0.0304	CbGeAlD
Lomefloxacin—SLC22A5—liver—stomach cancer	0.000186	0.0302	CbGeAlD
Lomefloxacin—ABCC2—lymph node—stomach cancer	0.000184	0.0299	CbGeAlD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KLF6—stomach cancer	0.000181	0.0154	CbGpPWpGaD
Lomefloxacin—Bradycardia—Epirubicin—stomach cancer	0.000179	0.000739	CcSEcCtD
Lomefloxacin—Renal failure—Doxorubicin—stomach cancer	0.000178	0.000736	CcSEcCtD
Lomefloxacin—TOP2A—Gastric Cancer Network 1—APC—stomach cancer	0.000178	0.0151	CbGpPWpGaD
Lomefloxacin—Erythema multiforme—Methotrexate—stomach cancer	0.000178	0.000733	CcSEcCtD
Lomefloxacin—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000178	0.000733	CcSEcCtD
Lomefloxacin—Dizziness—Irinotecan—stomach cancer	0.000177	0.000731	CcSEcCtD
Lomefloxacin—Stomatitis—Doxorubicin—stomach cancer	0.000177	0.000729	CcSEcCtD
Lomefloxacin—Anorexia—Docetaxel—stomach cancer	0.000177	0.000729	CcSEcCtD
Lomefloxacin—Shock—Capecitabine—stomach cancer	0.000176	0.000728	CcSEcCtD
Lomefloxacin—Rhinitis—Epirubicin—stomach cancer	0.000176	0.000728	CcSEcCtD
Lomefloxacin—Conjunctivitis—Doxorubicin—stomach cancer	0.000176	0.000727	CcSEcCtD
Lomefloxacin—Hepatitis—Epirubicin—stomach cancer	0.000176	0.000726	CcSEcCtD
Lomefloxacin—Diarrhoea—Fluorouracil—stomach cancer	0.000176	0.000725	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Capecitabine—stomach cancer	0.000176	0.000725	CcSEcCtD
Lomefloxacin—Tinnitus—Methotrexate—stomach cancer	0.000175	0.000723	CcSEcCtD
Lomefloxacin—Tachycardia—Capecitabine—stomach cancer	0.000175	0.000723	CcSEcCtD
Lomefloxacin—Pharyngitis—Epirubicin—stomach cancer	0.000175	0.00072	CcSEcCtD
Lomefloxacin—Skin disorder—Capecitabine—stomach cancer	0.000174	0.000719	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Capecitabine—stomach cancer	0.000173	0.000716	CcSEcCtD
Lomefloxacin—Hypotension—Docetaxel—stomach cancer	0.000173	0.000715	CcSEcCtD
Lomefloxacin—Haematuria—Doxorubicin—stomach cancer	0.000173	0.000713	CcSEcCtD
Lomefloxacin—Epistaxis—Doxorubicin—stomach cancer	0.000171	0.000706	CcSEcCtD
Lomefloxacin—Anorexia—Capecitabine—stomach cancer	0.000171	0.000706	CcSEcCtD
Lomefloxacin—Vomiting—Irinotecan—stomach cancer	0.00017	0.000703	CcSEcCtD
Lomefloxacin—ABCC2—NRF2 pathway—BLVRB—stomach cancer	0.00017	0.0145	CbGpPWpGaD
Lomefloxacin—Dizziness—Fluorouracil—stomach cancer	0.00017	0.000701	CcSEcCtD
Lomefloxacin—Visual impairment—Epirubicin—stomach cancer	0.00017	0.0007	CcSEcCtD
Lomefloxacin—Agranulocytosis—Doxorubicin—stomach cancer	0.000169	0.000698	CcSEcCtD
Lomefloxacin—Rash—Irinotecan—stomach cancer	0.000169	0.000697	CcSEcCtD
Lomefloxacin—Dermatitis—Irinotecan—stomach cancer	0.000169	0.000697	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000169	0.000697	CcSEcCtD
Lomefloxacin—Chills—Methotrexate—stomach cancer	0.000169	0.000696	CcSEcCtD
Lomefloxacin—CYP1A2—liver—stomach cancer	0.000168	0.0274	CbGeAlD
Lomefloxacin—Headache—Irinotecan—stomach cancer	0.000168	0.000693	CcSEcCtD
Lomefloxacin—Hypotension—Capecitabine—stomach cancer	0.000168	0.000692	CcSEcCtD
Lomefloxacin—Insomnia—Docetaxel—stomach cancer	0.000168	0.000692	CcSEcCtD
Lomefloxacin—Paraesthesia—Docetaxel—stomach cancer	0.000166	0.000687	CcSEcCtD
Lomefloxacin—Erythema multiforme—Epirubicin—stomach cancer	0.000166	0.000686	CcSEcCtD
Lomefloxacin—Bradycardia—Doxorubicin—stomach cancer	0.000166	0.000684	CcSEcCtD
Lomefloxacin—Dyspnoea—Docetaxel—stomach cancer	0.000165	0.000682	CcSEcCtD
Lomefloxacin—Somnolence—Docetaxel—stomach cancer	0.000165	0.00068	CcSEcCtD
Lomefloxacin—Tinnitus—Epirubicin—stomach cancer	0.000164	0.000677	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000163	0.000674	CcSEcCtD
Lomefloxacin—Flushing—Epirubicin—stomach cancer	0.000163	0.000674	CcSEcCtD
Lomefloxacin—Vomiting—Fluorouracil—stomach cancer	0.000163	0.000674	CcSEcCtD
Lomefloxacin—Rhinitis—Doxorubicin—stomach cancer	0.000163	0.000673	CcSEcCtD
Lomefloxacin—Dyspepsia—Docetaxel—stomach cancer	0.000163	0.000673	CcSEcCtD
Lomefloxacin—Hepatitis—Doxorubicin—stomach cancer	0.000163	0.000672	CcSEcCtD
Lomefloxacin—Insomnia—Capecitabine—stomach cancer	0.000162	0.00067	CcSEcCtD
Lomefloxacin—Rash—Fluorouracil—stomach cancer	0.000162	0.000668	CcSEcCtD
Lomefloxacin—Dermatitis—Fluorouracil—stomach cancer	0.000162	0.000667	CcSEcCtD
Lomefloxacin—Pharyngitis—Doxorubicin—stomach cancer	0.000162	0.000667	CcSEcCtD
Lomefloxacin—Paraesthesia—Capecitabine—stomach cancer	0.000161	0.000665	CcSEcCtD
Lomefloxacin—Decreased appetite—Docetaxel—stomach cancer	0.000161	0.000665	CcSEcCtD
Lomefloxacin—Headache—Fluorouracil—stomach cancer	0.000161	0.000664	CcSEcCtD
Lomefloxacin—Dysgeusia—Methotrexate—stomach cancer	0.00016	0.000661	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—KMT2A—stomach cancer	0.00016	0.0136	CbGpPWpGaD
Lomefloxacin—Dyspnoea—Capecitabine—stomach cancer	0.00016	0.00066	CcSEcCtD
Lomefloxacin—Fatigue—Docetaxel—stomach cancer	0.00016	0.000659	CcSEcCtD
Lomefloxacin—Nausea—Irinotecan—stomach cancer	0.000159	0.000657	CcSEcCtD
Lomefloxacin—Constipation—Docetaxel—stomach cancer	0.000158	0.000654	CcSEcCtD
Lomefloxacin—Back pain—Methotrexate—stomach cancer	0.000158	0.000653	CcSEcCtD
Lomefloxacin—Dyspepsia—Capecitabine—stomach cancer	0.000158	0.000652	CcSEcCtD
Lomefloxacin—Chills—Epirubicin—stomach cancer	0.000158	0.000651	CcSEcCtD
Lomefloxacin—CYP1A2—Fatty Acid Omega Oxidation—CYP2A6—stomach cancer	0.000157	0.0134	CbGpPWpGaD
Lomefloxacin—Arrhythmia—Epirubicin—stomach cancer	0.000157	0.000649	CcSEcCtD
Lomefloxacin—Visual impairment—Doxorubicin—stomach cancer	0.000157	0.000647	CcSEcCtD
Lomefloxacin—Decreased appetite—Capecitabine—stomach cancer	0.000156	0.000644	CcSEcCtD
Lomefloxacin—Fatigue—Capecitabine—stomach cancer	0.000155	0.000638	CcSEcCtD
Lomefloxacin—Erythema multiforme—Doxorubicin—stomach cancer	0.000154	0.000635	CcSEcCtD
Lomefloxacin—Constipation—Capecitabine—stomach cancer	0.000153	0.000633	CcSEcCtD
Lomefloxacin—Feeling abnormal—Docetaxel—stomach cancer	0.000153	0.00063	CcSEcCtD
Lomefloxacin—Nausea—Fluorouracil—stomach cancer	0.000152	0.000629	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Methotrexate—stomach cancer	0.000152	0.000627	CcSEcCtD
Lomefloxacin—Tinnitus—Doxorubicin—stomach cancer	0.000152	0.000626	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Docetaxel—stomach cancer	0.000152	0.000625	CcSEcCtD
Lomefloxacin—Anaemia—Methotrexate—stomach cancer	0.000151	0.000624	CcSEcCtD
Lomefloxacin—Flushing—Doxorubicin—stomach cancer	0.000151	0.000623	CcSEcCtD
Lomefloxacin—Flatulence—Epirubicin—stomach cancer	0.000151	0.000623	CcSEcCtD
Lomefloxacin—Tension—Epirubicin—stomach cancer	0.00015	0.00062	CcSEcCtD
Lomefloxacin—Dysgeusia—Epirubicin—stomach cancer	0.00015	0.000619	CcSEcCtD
Lomefloxacin—Nervousness—Epirubicin—stomach cancer	0.000149	0.000614	CcSEcCtD
Lomefloxacin—Back pain—Epirubicin—stomach cancer	0.000148	0.000611	CcSEcCtD
Lomefloxacin—Feeling abnormal—Capecitabine—stomach cancer	0.000148	0.00061	CcSEcCtD
Lomefloxacin—Malaise—Methotrexate—stomach cancer	0.000148	0.000609	CcSEcCtD
Lomefloxacin—Muscle spasms—Epirubicin—stomach cancer	0.000147	0.000608	CcSEcCtD
Lomefloxacin—Vertigo—Methotrexate—stomach cancer	0.000147	0.000607	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Capecitabine—stomach cancer	0.000147	0.000605	CcSEcCtD
Lomefloxacin—Abdominal pain—Docetaxel—stomach cancer	0.000146	0.000604	CcSEcCtD
Lomefloxacin—Leukopenia—Methotrexate—stomach cancer	0.000146	0.000604	CcSEcCtD
Lomefloxacin—Chills—Doxorubicin—stomach cancer	0.000146	0.000603	CcSEcCtD
Lomefloxacin—Arrhythmia—Doxorubicin—stomach cancer	0.000145	0.0006	CcSEcCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—DNMT1—stomach cancer	0.000144	0.0122	CbGpPWpGaD
Lomefloxacin—Cough—Methotrexate—stomach cancer	0.000143	0.000589	CcSEcCtD
Lomefloxacin—Urticaria—Capecitabine—stomach cancer	0.000143	0.000588	CcSEcCtD
Lomefloxacin—SLC22A5—lymph node—stomach cancer	0.000142	0.0232	CbGeAlD
Lomefloxacin—Ill-defined disorder—Epirubicin—stomach cancer	0.000142	0.000586	CcSEcCtD
Lomefloxacin—Abdominal pain—Capecitabine—stomach cancer	0.000142	0.000585	CcSEcCtD
Lomefloxacin—Convulsion—Methotrexate—stomach cancer	0.000142	0.000585	CcSEcCtD
Lomefloxacin—Anaemia—Epirubicin—stomach cancer	0.000142	0.000584	CcSEcCtD
Lomefloxacin—Agitation—Epirubicin—stomach cancer	0.000141	0.000581	CcSEcCtD
Lomefloxacin—Flatulence—Doxorubicin—stomach cancer	0.00014	0.000576	CcSEcCtD
Lomefloxacin—Arthralgia—Methotrexate—stomach cancer	0.000139	0.000575	CcSEcCtD
Lomefloxacin—Myalgia—Methotrexate—stomach cancer	0.000139	0.000575	CcSEcCtD
Lomefloxacin—Chest pain—Methotrexate—stomach cancer	0.000139	0.000575	CcSEcCtD
Lomefloxacin—Tension—Doxorubicin—stomach cancer	0.000139	0.000574	CcSEcCtD
Lomefloxacin—Dysgeusia—Doxorubicin—stomach cancer	0.000139	0.000573	CcSEcCtD
Lomefloxacin—Malaise—Epirubicin—stomach cancer	0.000138	0.00057	CcSEcCtD
Lomefloxacin—Discomfort—Methotrexate—stomach cancer	0.000138	0.000568	CcSEcCtD
Lomefloxacin—Nervousness—Doxorubicin—stomach cancer	0.000138	0.000568	CcSEcCtD
Lomefloxacin—Vertigo—Epirubicin—stomach cancer	0.000138	0.000568	CcSEcCtD
Lomefloxacin—Syncope—Epirubicin—stomach cancer	0.000137	0.000567	CcSEcCtD
Lomefloxacin—Leukopenia—Epirubicin—stomach cancer	0.000137	0.000566	CcSEcCtD
Lomefloxacin—Back pain—Doxorubicin—stomach cancer	0.000137	0.000566	CcSEcCtD
Lomefloxacin—Hypersensitivity—Docetaxel—stomach cancer	0.000137	0.000563	CcSEcCtD
Lomefloxacin—Muscle spasms—Doxorubicin—stomach cancer	0.000136	0.000562	CcSEcCtD
Lomefloxacin—Confusional state—Methotrexate—stomach cancer	0.000135	0.000556	CcSEcCtD
Lomefloxacin—Loss of consciousness—Epirubicin—stomach cancer	0.000135	0.000555	CcSEcCtD
Lomefloxacin—Cough—Epirubicin—stomach cancer	0.000134	0.000551	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Methotrexate—stomach cancer	0.000134	0.000551	CcSEcCtD
Lomefloxacin—Asthenia—Docetaxel—stomach cancer	0.000133	0.000549	CcSEcCtD
Lomefloxacin—Convulsion—Epirubicin—stomach cancer	0.000133	0.000548	CcSEcCtD
Lomefloxacin—Hypertension—Epirubicin—stomach cancer	0.000132	0.000546	CcSEcCtD
Lomefloxacin—Hypersensitivity—Capecitabine—stomach cancer	0.000132	0.000545	CcSEcCtD
Lomefloxacin—CYP1A2—Xenobiotics—CYP2A6—stomach cancer	0.000132	0.0112	CbGpPWpGaD
Lomefloxacin—Ill-defined disorder—Doxorubicin—stomach cancer	0.000131	0.000543	CcSEcCtD
Lomefloxacin—Pruritus—Docetaxel—stomach cancer	0.000131	0.000541	CcSEcCtD
Lomefloxacin—Anaemia—Doxorubicin—stomach cancer	0.000131	0.00054	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Methotrexate—stomach cancer	0.000131	0.00054	CcSEcCtD
Lomefloxacin—Arthralgia—Epirubicin—stomach cancer	0.00013	0.000538	CcSEcCtD
Lomefloxacin—Chest pain—Epirubicin—stomach cancer	0.00013	0.000538	CcSEcCtD
Lomefloxacin—Myalgia—Epirubicin—stomach cancer	0.00013	0.000538	CcSEcCtD
Lomefloxacin—Agitation—Doxorubicin—stomach cancer	0.00013	0.000537	CcSEcCtD
Lomefloxacin—Anxiety—Epirubicin—stomach cancer	0.00013	0.000536	CcSEcCtD
Lomefloxacin—Skin disorder—Methotrexate—stomach cancer	0.00013	0.000535	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Methotrexate—stomach cancer	0.000129	0.000533	CcSEcCtD
Lomefloxacin—Discomfort—Epirubicin—stomach cancer	0.000129	0.000532	CcSEcCtD
Lomefloxacin—Asthenia—Capecitabine—stomach cancer	0.000129	0.000531	CcSEcCtD
Lomefloxacin—Malaise—Doxorubicin—stomach cancer	0.000128	0.000527	CcSEcCtD
Lomefloxacin—Dry mouth—Epirubicin—stomach cancer	0.000127	0.000526	CcSEcCtD
Lomefloxacin—Vertigo—Doxorubicin—stomach cancer	0.000127	0.000525	CcSEcCtD
Lomefloxacin—Anorexia—Methotrexate—stomach cancer	0.000127	0.000525	CcSEcCtD
Lomefloxacin—Syncope—Doxorubicin—stomach cancer	0.000127	0.000524	CcSEcCtD
Lomefloxacin—Pruritus—Capecitabine—stomach cancer	0.000127	0.000524	CcSEcCtD
Lomefloxacin—Leukopenia—Doxorubicin—stomach cancer	0.000127	0.000523	CcSEcCtD
Lomefloxacin—Diarrhoea—Docetaxel—stomach cancer	0.000127	0.000523	CcSEcCtD
Lomefloxacin—CYP1A2—Tamoxifen metabolism—CYP2A6—stomach cancer	0.000127	0.0108	CbGpPWpGaD
Lomefloxacin—Confusional state—Epirubicin—stomach cancer	0.000126	0.00052	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SERPINB2—stomach cancer	0.000125	0.0107	CbGpPWpGaD
Lomefloxacin—Anaphylactic shock—Epirubicin—stomach cancer	0.000125	0.000516	CcSEcCtD
Lomefloxacin—Oedema—Epirubicin—stomach cancer	0.000125	0.000516	CcSEcCtD
Lomefloxacin—Hypotension—Methotrexate—stomach cancer	0.000125	0.000515	CcSEcCtD
Lomefloxacin—Loss of consciousness—Doxorubicin—stomach cancer	0.000125	0.000514	CcSEcCtD
Lomefloxacin—Cough—Doxorubicin—stomach cancer	0.000124	0.00051	CcSEcCtD
Lomefloxacin—Shock—Epirubicin—stomach cancer	0.000123	0.000507	CcSEcCtD
Lomefloxacin—Convulsion—Doxorubicin—stomach cancer	0.000123	0.000507	CcSEcCtD
Lomefloxacin—Diarrhoea—Capecitabine—stomach cancer	0.000123	0.000507	CcSEcCtD
Lomefloxacin—Dizziness—Docetaxel—stomach cancer	0.000123	0.000506	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BID—stomach cancer	0.000122	0.0104	CbGpPWpGaD
Lomefloxacin—Thrombocytopenia—Epirubicin—stomach cancer	0.000122	0.000505	CcSEcCtD
Lomefloxacin—Hypertension—Doxorubicin—stomach cancer	0.000122	0.000505	CcSEcCtD
Lomefloxacin—Tachycardia—Epirubicin—stomach cancer	0.000122	0.000503	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000122	0.000502	CcSEcCtD
Lomefloxacin—Skin disorder—Epirubicin—stomach cancer	0.000121	0.000501	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Epirubicin—stomach cancer	0.000121	0.000499	CcSEcCtD
Lomefloxacin—Insomnia—Methotrexate—stomach cancer	0.000121	0.000498	CcSEcCtD
Lomefloxacin—Chest pain—Doxorubicin—stomach cancer	0.000121	0.000498	CcSEcCtD
Lomefloxacin—Arthralgia—Doxorubicin—stomach cancer	0.000121	0.000498	CcSEcCtD
Lomefloxacin—Myalgia—Doxorubicin—stomach cancer	0.000121	0.000498	CcSEcCtD
Lomefloxacin—Anxiety—Doxorubicin—stomach cancer	0.00012	0.000496	CcSEcCtD
Lomefloxacin—Paraesthesia—Methotrexate—stomach cancer	0.00012	0.000495	CcSEcCtD
Lomefloxacin—Discomfort—Doxorubicin—stomach cancer	0.000119	0.000492	CcSEcCtD
Lomefloxacin—Anorexia—Epirubicin—stomach cancer	0.000119	0.000492	CcSEcCtD
Lomefloxacin—Dyspnoea—Methotrexate—stomach cancer	0.000119	0.000491	CcSEcCtD
Lomefloxacin—Somnolence—Methotrexate—stomach cancer	0.000119	0.00049	CcSEcCtD
Lomefloxacin—Dizziness—Capecitabine—stomach cancer	0.000119	0.00049	CcSEcCtD
Lomefloxacin—Dry mouth—Doxorubicin—stomach cancer	0.000118	0.000487	CcSEcCtD
Lomefloxacin—Vomiting—Docetaxel—stomach cancer	0.000118	0.000486	CcSEcCtD
Lomefloxacin—Dyspepsia—Methotrexate—stomach cancer	0.000118	0.000485	CcSEcCtD
Lomefloxacin—Rash—Docetaxel—stomach cancer	0.000117	0.000482	CcSEcCtD
Lomefloxacin—Hypotension—Epirubicin—stomach cancer	0.000117	0.000482	CcSEcCtD
Lomefloxacin—Dermatitis—Docetaxel—stomach cancer	0.000117	0.000482	CcSEcCtD
Lomefloxacin—Confusional state—Doxorubicin—stomach cancer	0.000117	0.000481	CcSEcCtD
Lomefloxacin—Decreased appetite—Methotrexate—stomach cancer	0.000116	0.000479	CcSEcCtD
Lomefloxacin—Headache—Docetaxel—stomach cancer	0.000116	0.000479	CcSEcCtD
Lomefloxacin—Oedema—Doxorubicin—stomach cancer	0.000116	0.000477	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Doxorubicin—stomach cancer	0.000116	0.000477	CcSEcCtD
Lomefloxacin—Fatigue—Methotrexate—stomach cancer	0.000115	0.000475	CcSEcCtD
Lomefloxacin—ABCC2—ABC-family proteins mediated transport—APOA1—stomach cancer	0.000115	0.00977	CbGpPWpGaD
Lomefloxacin—Vomiting—Capecitabine—stomach cancer	0.000114	0.000471	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000114	0.00047	CcSEcCtD
Lomefloxacin—Shock—Doxorubicin—stomach cancer	0.000114	0.000469	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Doxorubicin—stomach cancer	0.000113	0.000467	CcSEcCtD
Lomefloxacin—Rash—Capecitabine—stomach cancer	0.000113	0.000467	CcSEcCtD
Lomefloxacin—Insomnia—Epirubicin—stomach cancer	0.000113	0.000466	CcSEcCtD
Lomefloxacin—Dermatitis—Capecitabine—stomach cancer	0.000113	0.000466	CcSEcCtD
Lomefloxacin—Tachycardia—Doxorubicin—stomach cancer	0.000113	0.000466	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP10—stomach cancer	0.000113	0.00958	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FST—stomach cancer	0.000113	0.00958	CbGpPWpGaD
Lomefloxacin—Headache—Capecitabine—stomach cancer	0.000112	0.000464	CcSEcCtD
Lomefloxacin—Skin disorder—Doxorubicin—stomach cancer	0.000112	0.000464	CcSEcCtD
Lomefloxacin—Paraesthesia—Epirubicin—stomach cancer	0.000112	0.000463	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Doxorubicin—stomach cancer	0.000112	0.000461	CcSEcCtD
Lomefloxacin—Dyspnoea—Epirubicin—stomach cancer	0.000111	0.00046	CcSEcCtD
Lomefloxacin—Somnolence—Epirubicin—stomach cancer	0.000111	0.000459	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.00011	0.00939	CbGpPWpGaD
Lomefloxacin—Anorexia—Doxorubicin—stomach cancer	0.00011	0.000455	CcSEcCtD
Lomefloxacin—Nausea—Docetaxel—stomach cancer	0.00011	0.000454	CcSEcCtD
Lomefloxacin—Feeling abnormal—Methotrexate—stomach cancer	0.00011	0.000454	CcSEcCtD
Lomefloxacin—Dyspepsia—Epirubicin—stomach cancer	0.00011	0.000454	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Methotrexate—stomach cancer	0.000109	0.000451	CcSEcCtD
Lomefloxacin—Decreased appetite—Epirubicin—stomach cancer	0.000109	0.000448	CcSEcCtD
Lomefloxacin—Hypotension—Doxorubicin—stomach cancer	0.000108	0.000446	CcSEcCtD
Lomefloxacin—Fatigue—Epirubicin—stomach cancer	0.000108	0.000445	CcSEcCtD
Lomefloxacin—Constipation—Epirubicin—stomach cancer	0.000107	0.000441	CcSEcCtD
Lomefloxacin—Nausea—Capecitabine—stomach cancer	0.000107	0.00044	CcSEcCtD
Lomefloxacin—Urticaria—Methotrexate—stomach cancer	0.000106	0.000438	CcSEcCtD
Lomefloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	0.000106	0.00901	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—RORA—stomach cancer	0.000106	0.00898	CbGpPWpGaD
Lomefloxacin—Abdominal pain—Methotrexate—stomach cancer	0.000106	0.000436	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000105	0.000435	CcSEcCtD
Lomefloxacin—Insomnia—Doxorubicin—stomach cancer	0.000105	0.000432	CcSEcCtD
Lomefloxacin—Paraesthesia—Doxorubicin—stomach cancer	0.000104	0.000429	CcSEcCtD
Lomefloxacin—CYP1A2—Tryptophan metabolism—ECHS1—stomach cancer	0.000104	0.00883	CbGpPWpGaD
Lomefloxacin—Dyspnoea—Doxorubicin—stomach cancer	0.000103	0.000425	CcSEcCtD
Lomefloxacin—Feeling abnormal—Epirubicin—stomach cancer	0.000103	0.000425	CcSEcCtD
Lomefloxacin—Somnolence—Doxorubicin—stomach cancer	0.000103	0.000424	CcSEcCtD
Lomefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—stomach cancer	0.000103	0.00874	CbGpPWpGaD
Lomefloxacin—Gastrointestinal pain—Epirubicin—stomach cancer	0.000102	0.000422	CcSEcCtD
Lomefloxacin—Dyspepsia—Doxorubicin—stomach cancer	0.000102	0.00042	CcSEcCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TYMS—stomach cancer	0.000101	0.00857	CbGpPWpGaD
Lomefloxacin—Decreased appetite—Doxorubicin—stomach cancer	0.000101	0.000415	CcSEcCtD
Lomefloxacin—Fatigue—Doxorubicin—stomach cancer	9.97e-05	0.000411	CcSEcCtD
Lomefloxacin—Urticaria—Epirubicin—stomach cancer	9.93e-05	0.00041	CcSEcCtD
Lomefloxacin—Constipation—Doxorubicin—stomach cancer	9.89e-05	0.000408	CcSEcCtD
Lomefloxacin—Abdominal pain—Epirubicin—stomach cancer	9.88e-05	0.000408	CcSEcCtD
Lomefloxacin—Hypersensitivity—Methotrexate—stomach cancer	9.84e-05	0.000406	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RARB—stomach cancer	9.83e-05	0.00836	CbGpPWpGaD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—stomach cancer	9.83e-05	0.00836	CbGpPWpGaD
Lomefloxacin—Asthenia—Methotrexate—stomach cancer	9.58e-05	0.000395	CcSEcCtD
Lomefloxacin—Feeling abnormal—Doxorubicin—stomach cancer	9.53e-05	0.000393	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—PRKAA1—stomach cancer	9.52e-05	0.0081	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC1A2—stomach cancer	9.46e-05	0.00805	CbGpPWpGaD
Lomefloxacin—Gastrointestinal pain—Doxorubicin—stomach cancer	9.46e-05	0.00039	CcSEcCtD
Lomefloxacin—Pruritus—Methotrexate—stomach cancer	9.45e-05	0.00039	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—AHR—stomach cancer	9.44e-05	0.00803	CbGpPWpGaD
Lomefloxacin—TOP2A—Gastric Cancer Network 2—MYC—stomach cancer	9.29e-05	0.0079	CbGpPWpGaD
Lomefloxacin—CYP1A2—Estrogen metabolism—GSTM1—stomach cancer	9.23e-05	0.00785	CbGpPWpGaD
Lomefloxacin—Hypersensitivity—Epirubicin—stomach cancer	9.21e-05	0.00038	CcSEcCtD
Lomefloxacin—Urticaria—Doxorubicin—stomach cancer	9.19e-05	0.000379	CcSEcCtD
Lomefloxacin—Abdominal pain—Doxorubicin—stomach cancer	9.14e-05	0.000377	CcSEcCtD
Lomefloxacin—Diarrhoea—Methotrexate—stomach cancer	9.14e-05	0.000377	CcSEcCtD
Lomefloxacin—TOP2A—Gastric Cancer Network 2—EGFR—stomach cancer	9.09e-05	0.00773	CbGpPWpGaD
Lomefloxacin—Asthenia—Epirubicin—stomach cancer	8.97e-05	0.00037	CcSEcCtD
Lomefloxacin—Pruritus—Epirubicin—stomach cancer	8.84e-05	0.000365	CcSEcCtD
Lomefloxacin—Dizziness—Methotrexate—stomach cancer	8.83e-05	0.000364	CcSEcCtD
Lomefloxacin—CYP1A2—Melatonin metabolism and effects—ADRB1—stomach cancer	8.81e-05	0.00749	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2D—stomach cancer	8.68e-05	0.00739	CbGpPWpGaD
Lomefloxacin—Diarrhoea—Epirubicin—stomach cancer	8.55e-05	0.000353	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IGFBP3—stomach cancer	8.54e-05	0.00726	CbGpPWpGaD
Lomefloxacin—Hypersensitivity—Doxorubicin—stomach cancer	8.52e-05	0.000352	CcSEcCtD
Lomefloxacin—Vomiting—Methotrexate—stomach cancer	8.49e-05	0.00035	CcSEcCtD
Lomefloxacin—Rash—Methotrexate—stomach cancer	8.42e-05	0.000347	CcSEcCtD
Lomefloxacin—Dermatitis—Methotrexate—stomach cancer	8.41e-05	0.000347	CcSEcCtD
Lomefloxacin—Headache—Methotrexate—stomach cancer	8.37e-05	0.000345	CcSEcCtD
Lomefloxacin—Asthenia—Doxorubicin—stomach cancer	8.3e-05	0.000342	CcSEcCtD
Lomefloxacin—Dizziness—Epirubicin—stomach cancer	8.26e-05	0.000341	CcSEcCtD
Lomefloxacin—Pruritus—Doxorubicin—stomach cancer	8.18e-05	0.000338	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—CLCN3—stomach cancer	8.07e-05	0.00687	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—AHR—stomach cancer	8.07e-05	0.00686	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—AHR—stomach cancer	8.07e-05	0.00686	CbGpPWpGaD
Lomefloxacin—Vomiting—Epirubicin—stomach cancer	7.95e-05	0.000328	CcSEcCtD
Lomefloxacin—ABCC2—NRF2 pathway—TGFA—stomach cancer	7.93e-05	0.00675	CbGpPWpGaD
Lomefloxacin—Nausea—Methotrexate—stomach cancer	7.93e-05	0.000327	CcSEcCtD
Lomefloxacin—Diarrhoea—Doxorubicin—stomach cancer	7.91e-05	0.000327	CcSEcCtD
Lomefloxacin—Rash—Epirubicin—stomach cancer	7.88e-05	0.000325	CcSEcCtD
Lomefloxacin—Dermatitis—Epirubicin—stomach cancer	7.87e-05	0.000325	CcSEcCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—stomach cancer	7.85e-05	0.00668	CbGpPWpGaD
Lomefloxacin—Headache—Epirubicin—stomach cancer	7.83e-05	0.000323	CcSEcCtD
Lomefloxacin—ABCC2—NRF2 pathway—SERPINA1—stomach cancer	7.82e-05	0.00665	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—PPP2R1A—stomach cancer	7.77e-05	0.00661	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDKN2D—stomach cancer	7.77e-05	0.0066	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ANXA1—stomach cancer	7.66e-05	0.00651	CbGpPWpGaD
Lomefloxacin—Dizziness—Doxorubicin—stomach cancer	7.65e-05	0.000316	CcSEcCtD
Lomefloxacin—TOP2A—Gastric Cancer Network 2—TP53—stomach cancer	7.63e-05	0.00649	CbGpPWpGaD
Lomefloxacin—Nausea—Epirubicin—stomach cancer	7.42e-05	0.000306	CcSEcCtD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—ALOX5—stomach cancer	7.36e-05	0.00626	CbGpPWpGaD
Lomefloxacin—Vomiting—Doxorubicin—stomach cancer	7.35e-05	0.000303	CcSEcCtD
Lomefloxacin—Rash—Doxorubicin—stomach cancer	7.29e-05	0.000301	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—GADD45A—stomach cancer	7.29e-05	0.0062	CbGpPWpGaD
Lomefloxacin—Dermatitis—Doxorubicin—stomach cancer	7.28e-05	0.000301	CcSEcCtD
Lomefloxacin—Headache—Doxorubicin—stomach cancer	7.24e-05	0.000299	CcSEcCtD
Lomefloxacin—ABCC2—NRF2 pathway—CYP2A6—stomach cancer	7.15e-05	0.00608	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—TYMS—stomach cancer	7.09e-05	0.00603	CbGpPWpGaD
Lomefloxacin—Nausea—Doxorubicin—stomach cancer	6.87e-05	0.000283	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—stomach cancer	6.66e-05	0.00567	CbGpPWpGaD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—AKR1C3—stomach cancer	6.15e-05	0.00523	CbGpPWpGaD
Lomefloxacin—CYP1A2—Estrogen Receptor Pathway—JUN—stomach cancer	6.09e-05	0.00518	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—HBEGF—stomach cancer	5.65e-05	0.00481	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—stomach cancer	5.56e-05	0.00473	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDK4—stomach cancer	5.53e-05	0.0047	CbGpPWpGaD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A6—stomach cancer	5.47e-05	0.00465	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SMAD4—stomach cancer	5.47e-05	0.00465	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—AURKB—stomach cancer	5.45e-05	0.00464	CbGpPWpGaD
Lomefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP2A6—stomach cancer	5.4e-05	0.00459	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—stomach cancer	5.37e-05	0.00457	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—stomach cancer	5.32e-05	0.00452	CbGpPWpGaD
Lomefloxacin—CYP1A2—Estrogen Receptor Pathway—STAT3—stomach cancer	5.27e-05	0.00448	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—TYMS—stomach cancer	5.16e-05	0.00438	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—stomach cancer	5.07e-05	0.00431	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—GSTP1—stomach cancer	5.02e-05	0.00427	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—HMOX1—stomach cancer	4.95e-05	0.00421	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—stomach cancer	4.91e-05	0.00417	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—AURKB—stomach cancer	4.88e-05	0.00415	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC1A2—stomach cancer	4.81e-05	0.00409	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—GSTM1—stomach cancer	4.61e-05	0.00392	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	4.43e-05	0.00377	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—NPM1—stomach cancer	4.29e-05	0.00365	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—stomach cancer	4.22e-05	0.00359	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—stomach cancer	4.19e-05	0.00356	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase II conjugation—GSTT1—stomach cancer	4.07e-05	0.00346	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—stomach cancer	4.07e-05	0.00346	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—CDK4—stomach cancer	4.02e-05	0.00342	CbGpPWpGaD
Lomefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	3.98e-05	0.00338	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	3.94e-05	0.00335	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—stomach cancer	3.74e-05	0.00318	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	3.67e-05	0.00312	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—PPARG—stomach cancer	3.65e-05	0.00311	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—stomach cancer	3.57e-05	0.00304	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC1A2—stomach cancer	3.51e-05	0.00299	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—stomach cancer	3.45e-05	0.00294	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—stomach cancer	3.34e-05	0.00284	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—SERPINE1—stomach cancer	3.29e-05	0.0028	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—APEX1—stomach cancer	3.13e-05	0.00266	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	3.06e-05	0.0026	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	2.99e-05	0.00254	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CHEK2—stomach cancer	2.88e-05	0.00245	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—stomach cancer	2.86e-05	0.00243	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—PPP2R1A—stomach cancer	2.85e-05	0.00242	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	2.83e-05	0.00241	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase II conjugation—GSTP1—stomach cancer	2.82e-05	0.0024	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—APEX1—stomach cancer	2.8e-05	0.00238	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	2.7e-05	0.0023	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	2.7e-05	0.00229	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	2.62e-05	0.00222	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—TYMS—stomach cancer	2.6e-05	0.00221	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase II conjugation—GSTM1—stomach cancer	2.59e-05	0.00221	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—JUN—stomach cancer	2.59e-05	0.0022	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—ALB—stomach cancer	2.56e-05	0.00218	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	2.55e-05	0.00217	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—PPP2R1A—stomach cancer	2.55e-05	0.00217	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—stomach cancer	2.46e-05	0.00209	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—MAPK8—stomach cancer	2.45e-05	0.00208	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—GSTT1—stomach cancer	2.38e-05	0.00203	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	2.36e-05	0.002	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—CYP2A6—stomach cancer	2.35e-05	0.002	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—stomach cancer	2.34e-05	0.00199	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—stomach cancer	2.33e-05	0.00198	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—stomach cancer	2.33e-05	0.00198	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—TYMS—stomach cancer	2.32e-05	0.00198	CbGpPWpGaD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—stomach cancer	2.3e-05	0.00195	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—stomach cancer	2.29e-05	0.00194	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—AKR1C3—stomach cancer	2.26e-05	0.00192	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	2.23e-05	0.0019	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—stomach cancer	2.22e-05	0.00188	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	2.17e-05	0.00184	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—HMOX1—stomach cancer	2.17e-05	0.00184	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—stomach cancer	2.15e-05	0.00183	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	2.12e-05	0.0018	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	2.12e-05	0.0018	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—BIRC5—stomach cancer	2.09e-05	0.00178	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	2.05e-05	0.00175	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—stomach cancer	2.03e-05	0.00172	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	2.02e-05	0.00172	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	2e-05	0.0017	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—PRKCB—stomach cancer	1.99e-05	0.0017	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—stomach cancer	1.94e-05	0.00165	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	1.84e-05	0.00157	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDK4—stomach cancer	1.81e-05	0.00154	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—PRKCB—stomach cancer	1.78e-05	0.00152	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	1.78e-05	0.00151	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—stomach cancer	1.78e-05	0.00151	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—stomach cancer	1.74e-05	0.00148	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—stomach cancer	1.74e-05	0.00148	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—stomach cancer	1.74e-05	0.00148	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	1.72e-05	0.00146	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—TP53—stomach cancer	1.71e-05	0.00145	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—stomach cancer	1.66e-05	0.00141	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—stomach cancer	1.66e-05	0.00141	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—GSTP1—stomach cancer	1.65e-05	0.0014	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—stomach cancer	1.65e-05	0.0014	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—APOA1—stomach cancer	1.64e-05	0.0014	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—GSTP1—stomach cancer	1.63e-05	0.00138	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—HMOX1—stomach cancer	1.58e-05	0.00135	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—IL6—stomach cancer	1.57e-05	0.00133	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—stomach cancer	1.55e-05	0.00132	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—GSTM1—stomach cancer	1.52e-05	0.00129	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—GSTM1—stomach cancer	1.5e-05	0.00127	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ACAD8—stomach cancer	1.42e-05	0.00121	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—stomach cancer	1.4e-05	0.00119	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	1.39e-05	0.00118	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDKN2A—stomach cancer	1.39e-05	0.00118	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—stomach cancer	1.37e-05	0.00117	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—stomach cancer	1.31e-05	0.00111	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	1.3e-05	0.00111	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—stomach cancer	1.3e-05	0.00111	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—stomach cancer	1.27e-05	0.00108	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GMPR2—stomach cancer	1.27e-05	0.00108	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDKN1B—stomach cancer	1.23e-05	0.00104	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	1.22e-05	0.00104	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—RORA—stomach cancer	1.21e-05	0.00103	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—APOA1—stomach cancer	1.2e-05	0.00102	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CCND1—stomach cancer	1.17e-05	0.000995	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—IDH3B—stomach cancer	1.16e-05	0.000984	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SUCLG1—stomach cancer	1.16e-05	0.000984	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDKN1A—stomach cancer	1.13e-05	0.000963	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—stomach cancer	1.08e-05	0.000918	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NDUFS1—stomach cancer	1.08e-05	0.000915	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NDUFV1—stomach cancer	1.08e-05	0.000915	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	1.05e-05	0.000894	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—MYC—stomach cancer	1.05e-05	0.000893	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—MAPK1—stomach cancer	1.03e-05	0.000873	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—MAPK3—stomach cancer	9.65e-06	0.000821	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PGLS—stomach cancer	9.59e-06	0.000815	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—BLVRB—stomach cancer	9.59e-06	0.000815	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ALB—stomach cancer	9.51e-06	0.000809	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—MYC—stomach cancer	9.39e-06	0.000798	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—MAPK1—stomach cancer	9.18e-06	0.000781	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PPAP2A—stomach cancer	9.15e-06	0.000778	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	8.8e-06	0.000748	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CKB—stomach cancer	8.15e-06	0.000693	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CA1—stomach cancer	8.15e-06	0.000693	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—FBP1—stomach cancer	8.15e-06	0.000693	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NDUFA2—stomach cancer	8.15e-06	0.000693	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—TP53—stomach cancer	7.71e-06	0.000656	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PLIN2—stomach cancer	7.67e-06	0.000652	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CA2—stomach cancer	7.46e-06	0.000634	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NT5E—stomach cancer	7.27e-06	0.000618	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PGAM1—stomach cancer	7.27e-06	0.000618	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PLCE1—stomach cancer	6.93e-06	0.00059	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ALDH7A1—stomach cancer	6.93e-06	0.00059	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—UMPS—stomach cancer	6.65e-06	0.000565	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PDHA1—stomach cancer	6.18e-06	0.000525	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ECHS1—stomach cancer	6.18e-06	0.000525	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—TYMP—stomach cancer	5.81e-06	0.000494	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—FADS1—stomach cancer	5.81e-06	0.000494	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SREBF2—stomach cancer	5.44e-06	0.000463	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—RORA—stomach cancer	5.38e-06	0.000457	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ALDOB—stomach cancer	5.04e-06	0.000428	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	4.75e-06	0.000404	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	4.74e-06	0.000403	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ALOX5—stomach cancer	4.68e-06	0.000398	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—DPYD—stomach cancer	4.61e-06	0.000392	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	4.18e-06	0.000355	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTT1—stomach cancer	4.07e-06	0.000346	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP2A6—stomach cancer	4.03e-06	0.000342	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—AKR1C3—stomach cancer	3.92e-06	0.000333	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ENO1—stomach cancer	3.82e-06	0.000325	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.75e-06	0.000319	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CD44—stomach cancer	3.39e-06	0.000288	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	3.28e-06	0.000279	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PPP2R1A—stomach cancer	2.88e-06	0.000245	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTP1—stomach cancer	2.82e-06	0.00024	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HMOX1—stomach cancer	2.78e-06	0.000237	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—TYMS—stomach cancer	2.63e-06	0.000223	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTM1—stomach cancer	2.59e-06	0.000221	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ERCC2—stomach cancer	2.44e-06	0.000207	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—MTHFR—stomach cancer	2.29e-06	0.000195	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CAV1—stomach cancer	2.12e-06	0.00018	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—APOA1—stomach cancer	2.11e-06	0.000179	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.02e-06	0.000172	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PPARG—stomach cancer	1.86e-06	0.000158	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ALB—stomach cancer	1.67e-06	0.000142	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NOS3—stomach cancer	1.6e-06	0.000136	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PTGS2—stomach cancer	1.46e-06	0.000124	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CA—stomach cancer	9e-07	7.65e-05	CbGpPWpGaD
